Aim: Hyperplasia suppressor gene/mitofusion-2 (HSG/Mfn2) is a hyperplasia suppressor gene and an essential component of mitochondrial fusion machinery; however, the association between the single nucleotide polymorphism (SNP) of HSG/Mfn2 and hypertension is unclear. Methods: In this study, 542 normotensive subjects (NT group) and 539 hypertensive patients (EH group) were screened for an association study between HSG/Mfn2 and hypertension.
Introduction
Vascular proliferative disorders, such as atherosclerosis and restenosis, are the most common causes/ effects of hypertension, but a common molecular mechanism remains elusive. In the previous study we identified and characterized a novel hyperplasia suppressor gene from rat, named HSG (later re-named mitofusin-2), located on the short (p) arm of chromosome 1 at position 36.22 1) . HSG/Mfn2 expression was markedly reduced in hyper-proliferative vascular smooth muscle cells (VSMCs) from spontaneously hypertensive rat arteries and balloon-injured Wistar Kyoto rat arteries. Overexpression of HSG/Mfn2 overtly suppressed serumevoked VSMC proliferation in culture, and blocked balloon injury-induced neointimal VSMC proliferation and restenosis in rat carotid arteries 1) . Recently, several studies indicated that the HSG/Mfn2 anti-proliferative effect was mediated by the inhibition of extracellular signal-regulated kinase/mitogen-activated protein kinases (ERK/MAPK) signaling and subsequent cell-cycle arrest [2] [3] [4] . Thus, rHSG/Mfn2 functions as a cell proliferation suppressor, whereas dysregulation of rHSG/Mfn2 results in proliferative disorders.
Beside the function noted above, HSG/Mfn2 was an essential component of mitochondrial fusion machinery. Cycles of mitochondrial fission and fusion ensured metabolite and mitochondrial DNA mixing and dictated organelle shape, number and bioenergetic functionality. As one of two fusion proteins, HSG/ Mfn2 belonged to the family of large GTP-binding proteins [5] [6] . If equilibrium between fusion and fission of mitochondria could not be maintained, energy metabolism, oxidation, calcium signaling and apoptosis disorder might be induced. Superoxide, for example, produced by mitochondria, could cause mitochondrial oxidative stress and contribute to the decline in mitochondrial functions; this general scenario is associated with a wide variety of pathologies, including hypertension and atherosclerosis 7) . Since HSG/Mfn2 is very important in VSMC negative regulation and a key gene in mitochondrial fusion, its function in hypertension is critical. Unfortunately, the function of HSG/Mfn2 in human hypertension has not been studied, although it was downregulated in hypertensive patients compared to healthy normotensive subjects in our previously study 8) .
Aim
This study was designed to investigate the association of HSG/Mfn2 SNPs in intron 2, which may provide clues to the pathogenetic understanding of essential hypertension.
Methods
This study was designed to investigate the difference in genotype and allele frequencies of the HSG/ Mfn2 in normotensive subjects and hypertensive patients. HSG/Mfn2 DNA sequence was analyzed by software (Proscan, Version 1.7, programs developed by Dr. Dan Prestridge, supplied online by the Advanced Biosciences Computing Center, University of Minnesota, USA) for transcription factors. Based on genetic analysis, literature review, and predictive analyses with an emphasis on gene expression regulation, seven candidate SNPs of HSG/Mfn2 (rs2236055, rs4240897, rs1474868, rs2336384, rs873458, rs873457, rs4846085) in intron 2, which included some critical promoters, were selected a priori.
Study Population
All the normotensive and hypertensive patients were screened at the physical examination center and hypertension clinic of Anzhen Hospital. A total of 542 healthy, normotensive subjects (NT group) and 539 hypertensive patients (EH group) were screened. BP was measured according to JNC-VII standards. The definition of normotension (SBP 130 mmHg and DBP 85 mmHg) and hypertension (SBP ≤140-≤179 mmHg, or DBP ≤90-≤109 mmHg) were based on the BP classification of the seventh report of the joint national committee on the prevention, detection, evaluation, and treatment of high blood pressure (JNC-VII) 9) . All patients were diagnosed as having essential hypertension and had never been treated with any antihypertensive drugs. BP was accurately measured three times on different days by experienced internists in the office with a mercury sphygmomanometer. The measurement was taken after the patients had been seated on a chair with their feet on the floor and their arms supported at heart level for 10 min 10) . None of the hypertensive patients had any known diseases, including secondary hypertension, diabetic disease and kidney diseases, etc., which might affect BP. This study complied with the Declaration of Helsinki. All participants signed a consent form, and the study was approved by the Hospital Ethics Committee.
DNA preparation
A 5-mL peripheral venous blood sample was drawn with the subject in the sitting position and with minimal use of a tourniquet. The blood was collected in an EDTA-Na anti-coagulated vacutainer tube. DNA was extracted using the PURGENE kit from Gentra Systems (Minneapolis, MN, USA) and stored at 20 in aliquots until required 11) .
Detection of genotype
The C_15953632_10(rs2236055) SNP genotyping kit was obtained from Applied Biosystems contained the two flanking primers and C-and T-specific probes labeled with VIC and FAM fluorescent dyes, respectively. This genotyping kit, TaqMan ® PCR Master Mix, No AmpErase ® UNG and approximately 5 ng genomic DNA were employed in a final volume of 5 L. A 7300 Real-Time PCR System was used for amplification, and the first step of the thermocycle was initial denaturation and activation at 95 for 10 minutes, followed by 40 cycles of 95 for 15 seconds and 60 for 1 minute. SNP kits for C_26207636_10 (rs4240897), C_1267235_20 (rs1474868), C_11461995_10 (rs2336384), C_8861262_10 ( r s 8 7 3 4 5 8 ) , C _ 1 1 4 6 1 9 9 6 _ 2 0 ( r s 8 7 3 4 5 7 ) , C_1267226_10 (rs4846085) were used and the genotypes detected following the instructions supplied by Applied Biosystems 12) .
Statistics
Values were expressed as the means SD. The association of genotypes with hypertension was analyzed using a chi-squared test. To compare indexes, including SBP, DBP and BMI, between the EH and NT groups, Student's t-test was used. To test for an association between each SNP and hypertension, we computed the overall genotypic test of association and the three genetic models (dominant, additive, and recessive). Multinomial logistic regression was used to study the effect of the seven SNPs on the hypertension status to incorporate other variables into the model. All association tests were analyzed by gender as well as in total and adjusted by age. All analyses were performed using SPSS v.11.5 (SPSS Inc., Chicago, USA) statistical analysis software. The frequency distribution of the haplotypes was calculated with a chi-squared test. A case-control-biased haplotype study, linkage disequilibrium, and the Hardy-Weinberg equilibrium were analyzed using HAPSTAT, version 3.0 Pro (Tammy Bailey, Danyu Lin and the University of North Carolina at Chapel Hill, Department of Biostatistics, NC, 27599-7420 USA). A two-tailed P-value 0.05 was considered significant 13) .
Results
The basic clinical characteristics of NT and EH groups are shown in Table 1 . There was no significant differences in age, triglyceride (TG), high density lipoprotein cholesterol (HDL-C), glucose level, serum blood urea nitrogen (BUN), creatinine clearance and uric acid between healthy normotensive subjects and hypertensive patients (P 0.05). Body mass index (BMI), total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) in the EH group were significantly higher than in the NT group (P 0.05) as well as in the female hypertensive and normotensive group. SBP and DBP in the EH group were significantly higher than in the NT group, which were the screening criteria for this case-control study.
SNPs and hypertension
The location and related mapping data were taken from NCBI ( Table 2) . By analyzing the sequence of HSG, we found many TATA boxes, CCAAT boxes and transcription start sites in intron 2. The expected and observed genotypic frequencies of each SNP in NT subjects were in good agreement with the predicted Hardy-Weinberg equilibrium values.
The genotype distributions of five SNPs (rs873457, rs2336384, rs1474868, rs4846085, rs2236055) were significantly different (P 0.05 for all) between NT and EH (TT:TC:CC 21.8%/24.9%: NT (n 542) EH (n 539) P NT (n 335) EH (n 325) P NT (n 207) EH (n 214) P for the five SNPs respectively, NT/EH) groups, and the allelic frequency was also different between the two groups (P 0.05 for all), although those of rs4240897 and rs873458 were not ( Table 3 , additional file 1). When comparing the dominant model, significant differences still existed (P 0.05 for all) but not in the recessive model. The genotype distribution of rs4240897 and rs873458, neither in the dominant nor in the recessive model was different in the two groups, while allelic frequency of rs4240897 was slightly different between the two groups (P 0.047). Interestingly, when subgrouped by sex, the genotype distribution and allelic frequency of all the SNPs (except rs873458) were significantly different in male NT and EH groups (P 0.05 for all) but not in female NT and EH groups. Only the allelic frequency of rs4240897 was obviously different in female NT and EH groups (P 0.01).
The variables, including BMI, age, and genotype, showed a marked association (P 0.05) with blood pressure; therefore, they underwent stepwise logistic regression to study the possible combined effect of seven mutants with other risk factors for hypertension. The remaining variables closely associated with BP were BMI and rs873457, after adjusting for age and sex (Table 4) .
In the haplotype-based case-control analysis, haplotypes were established in three representative common SNPs (Table 5) . For the total population as well as the male and female subjects, the C-G-A-A-A-C-C haplotype, established by rs873457, rs2336384, rs1474868, rs4846065, rs4240897, rsrs2236055 and rs873458, was significantly higher for essential hypertension patients than for control individuals (P 0.01 for all). As for other haplotypes, most were significantly different in the entire population and male subjects, while no significant differences existed between EH and NT groups in females.
Discussion
HSG/Mfn2, a newly found gene, has not been well studied. In 2003, we found 2 new novel SNPs and submitted them to the SNP database as ss4472758 and ss5606974. Recently, researchers have identified more than 30 Mfn2 mutations that could cause a form of Charcot-Marie-Tooth disease known as type 2A 14) . Now, there are about 188 SNPs of HSG/Mfn2 in the SNP database. Since HSG/Mfn2 is believed to be associated with hypertension, either as a cause or effect, the association between SNPs of HSG/ Mfn2 and hypertension is important, clinically and genetically.
In this study, seven SNPs in intron 2 were significantly different between the EH group and NT group, which may indicate an association between blood pressure and SNPs of HSG/Mfn2; however, since there were more males than females, with an increase of female participants, the differences between total EH and NT groups would become smaller. By genetic analysis, we found that the SNPs were in some transcript factor region which is important in the expression regulation of HSG/Mfn2. For example, many TATA boxes, CCAAT boxes and transcription start sites existed in intron 2, which promotes the transcript of HSG/Mfn2. Since our previous study identified the low expression of HSG/Mfn2 in hypertensive patients 8) , a mutation in this region may cause the downregulation of HSG/Mfn2 expression by suppressing the transcript of HSG/Mfn2, activate the ERK/ MAPK pathway 15) , and therefore lead to VSMC hyperplasia, although the precise mechanism of SNP resulting from HSG/Mfn2 as well as VSMC hyperplasia and hypertension remains unknown.
Just as we reported previously, HSG/Mfn2 could suppress ras protein, regulate the ERK/MAPK pathway, and also control the fusion of mitochondria 1) . In fact, beyond fusion, HSG/Mfn2 was also important in regulating mitochondrial metabolism, apoptosis, the shape of other organelles, and even progression through cell cycle [16] [17] . Mitochondria also produced most oxidative substances in cells which could cause hypertension and atherosclerosis 18) . In addition, the literature suggests the physiological functions for which mitochondria sequester Ca 2 were also critical to stimulate and control the rate of oxidative phosphorylation, to induce mitochondrial permeability transition (MPT) and apoptotic cell death, and to modify the shape of cytosolic Ca 2 pulses or transients. Fragmentation of mitochondria, which resulted in the dysfunction of Ca 2 regulation, is disastrous [19] [20] ; therefore, the mutation of HSG/Mfn2 intron 2, which controlls the expression of HSG, is very important, although more investigation is needed.
When the subjects in this study were grouped by sex, the male group exhibited a similar association with essential hypertension, whereas the female group did not. This result may indicate that rs2236055, rs4240897, rs1474868, rs2336384, rs873458, rs873457, rs4846085 are more significantly associated with hypertension in males. Because the distribution of SNPs in different genders as well as in total was in good agreement with Hardy-Weinberg equilibrium, this difference should not have been caused by a sample selection bias. More male subjects are subject to these risk factors than females in Chinese, such as heavy drinking, smoking, stress, being physically inactive, etc., while the SNPs noted above were susceptible to hypertension risk factors. Therefore, male hypertensive patients showed a different frequency of SNPs compared to their female opponents. Sex hormones may be another potential risk factor; however, since this study was only a pilot, further study is needed to explore the underlying mechanism.
Based on these results, we conclude that the six SNPs are associated with hypertension, particularly in male hypertensive patients. Multivariable analysis, used as above, also indicated an association between rs873457 and hypertension. Haplotype analysis is considered a good method for use in genetic studies of complex diseases while avoiding problems induced by multiple testing. In this study, six haplotypes of HSG/ Mfn2 were significantly associated with essential hypertension. Furthermore, the distribution of all polymorphisms was in Hardy-Weinberg equilibrium (data not shown), which suggests that the results of this study are unlikely to be biased by population stratification or admixture for essential hypertension. Together, it was strongly suggested that rs2236055, rs4240897, rs1474868, rs2336384, rs873458, rs873457 and rs4846085 may well be associated with essential hypertension.
The present population-based case-control study also showed gender-specific (male only) significant differences in genetic markers between essential hypertension patients and control individuals. Moreover, we noted a significant gene-by-gender interaction with BP traits in this study. Several studies have reported gender-specific effects of gene variants and gene-bygender interactions in human hypertension [21] [22] [23] [24] ; these data support our findings. As for the mechanism by which six common SNPs (rs2236055, rs4240897, rs1474868, rs2336384, rs873457 and rs4846085) might contribute to essential hypertension only in males, more studies are needed, although it was in accordance with the fact that males had higher incidences of essential hypertension than females 25) . As for SNP rs873458, both the genotypes and alleles exhibited similar frequencies in hypertensive patients as in healthy normotensive subjects, even after adjusting for age and gender.
Conclusion
To our knowledge, this was the first study to explore SNPs of HSG/Mfn2 and hypertension. We demonstrated that six of seven SNPs in intron 2 of HSG/Mfn2 were related with hypertension, particularly in males. Although this study gave some clues and novel information about HSG/Mfn2 SNPs and hypertension, further studies with a larger population, with the same number of males as females, and of different ethnicity are needed.
